[HTML][HTML] COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Abstract Coronavirus Disease 2019 (COVID-19) has been the most severe public health
challenge in this century. Two years after its emergence, the rapid development and …
challenge in this century. Two years after its emergence, the rapid development and …
Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis
WY Au, PPH Cheung - Bmj, 2022 - bmj.com
Objective To evaluate the effectiveness of heterologous and homologous covid-19 vaccine
regimens with and without boosting in preventing covid-19 related infection, hospital …
regimens with and without boosting in preventing covid-19 related infection, hospital …
Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar
LJ Abu-Raddad, H Chemaitelly… - … England Journal of …, 2022 - Mass Medical Soc
Background Waning of vaccine protection against coronavirus disease 2019 (Covid-19) and
the emergence of the omicron (or B. 1.1. 529) variant of the severe acute respiratory …
the emergence of the omicron (or B. 1.1. 529) variant of the severe acute respiratory …
[HTML][HTML] Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence …
Background Synthesising evidence on the long-term vaccine effectiveness of COVID-19
vaccines (BNT162b2 [Pfizer–BioNTech], mRNA-1273 [Moderna], ChAdOx1 nCoV-19 …
vaccines (BNT162b2 [Pfizer–BioNTech], mRNA-1273 [Moderna], ChAdOx1 nCoV-19 …
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study
JM Ferdinands, S Rao, BE Dixon, PK Mitchell… - Bmj, 2022 - bmj.com
Objective To estimate the effectiveness of mRNA vaccines against moderate and severe
covid-19 in adults by time since second, third, or fourth doses, and by age and …
covid-19 in adults by time since second, third, or fourth doses, and by age and …
[HTML][HTML] Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
COVID-19 is a worldwide pandemic caused by SARS-coronavirus-2 (SARS-CoV-2). Less
than a year after the emergence of the Covid-19 pandemic, many vaccines have arrived on …
than a year after the emergence of the Covid-19 pandemic, many vaccines have arrived on …
[HTML][HTML] Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study
Background Immunocompromised individuals are not optimally protected by COVID-19
vaccines and potentially require additional preventive interventions to mitigate the risk of …
vaccines and potentially require additional preventive interventions to mitigate the risk of …
[HTML][HTML] Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe
TL Wiemken, F Khan, L Puzniak, W Yang… - Scientific reports, 2023 - nature.com
Determining whether SARS-CoV-2 exhibits seasonality like other respiratory viruses is
critical for public health planning. We evaluated whether COVID-19 rates follow a seasonal …
critical for public health planning. We evaluated whether COVID-19 rates follow a seasonal …
[HTML][HTML] SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
The highly transmissible Omicron (B. 1.1. 529) variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) was first detected in late 2021. Initial Omicron waves were …
coronavirus 2 (SARS-CoV-2) was first detected in late 2021. Initial Omicron waves were …
A systematic review of coronavirus disease 2019 vaccine efficacy and effectiveness against severe acute respiratory syndrome coronavirus 2 infection and disease
Billions of doses of coronavirus disease 2019 (COVID-19) vaccines have been administered
globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS …
globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS …